VIP

Price range: $50.00 through $91.00

+ $9.99 Shipping · 7-day returns
Product specifications
  • Product: VIP
  • Analysis: Read the applicable published COA for its methods, results and reporting limits.
  • Class: Vasoactive Neuropeptide
  • Form: Lyophilized powder
  • CAS: 37221-79-7
  • Molecular Weight: 3326.82 g/mol
  • Storage: Store at -20°C (long term). Refrigerate after reconstitution.
  • Use: For in-vitro research use only. Not for human consumption.

Research Use Only. Not for Human Consumption.

SKU: VIP-VAR Category: Tags: immune signaling, neuroendocrine, neuropeptide, vasoactive intestinal peptide, vasodilation, VIP, VPAC
Secure checkout — Visa, Mastercard, Amex, Discover & Apple Pay

VIP is identified as vasoactive intestinal peptide in this research listing and is offered in two lyophilized amounts. The expanded name distinguishes the compound from the generic VIP abbreviation.

Configuration & published evidence

Match the expanded peptide name

Use the 5mg or 10mg configuration and the listed CAS 37221-79-7 when comparing records. Preserve both the peptide identity and selected amount on the purchasing record.

Available configurations, prices and associated published analysis records
ConfigurationPricePublished COA
5mg $50.00$10.00/mg labeled View record
10mg $91.00$9.10/mg labeled View record

Unit prices use the listed amount or volume, not measured purity or a dosing quantity. Confirm the selected price above. Each report identifies its own issuer, configuration, lot and methods; its publication does not identify the lot currently shipping.

Verified Purity
HPLC + Mass Spec Tested
Secure SSL Checkout

Batch documentation

Certificate of analysis

COA library

Apex Laboratory results for the listed configurations. Match the lot on your label with the report.

VIP - 10 mg

Lot
APX-2026-0510-V
COA issued
May 10, 2026
Issuing laboratory
Apex Laboratory
VIP chromatographic purity
99.888 % integrated detector area
VIP active content
10.0177 mg/vial
VPAC1 relative potency
100.05 % reference response potency
VPAC2 relative potency
100.08 % reference response potency

Chromatographic purity by analyte

Chromatographic purity by analyte for VIP - 10 mg, lot APX-2026-0510-V. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for VIP - 10 mg, lot APX-2026-0510-V. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

VIP - 5 mg

Lot
APX-2026-0430-V
COA issued
Apr 30, 2026
Issuing laboratory
Apex Laboratory
VIP chromatographic purity
99.866 % integrated detector area
VIP active content
4.9969 mg/vial
VPAC1 relative potency
100.05 % reference response potency
VPAC2 relative potency
100.08 % reference response potency

Chromatographic purity by analyte

Chromatographic purity by analyte for VIP - 5 mg, lot APX-2026-0430-V. Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.
About this graph

Recorded scalar results against the stated specification. Each row uses its own labeled scale; purity is detector-area purity, not active-material content.

Enlarge graph: Chromatographic purity by analyte (opens in a new tab)

Measured active content

Measured active content for VIP - 5 mg, lot APX-2026-0430-V. Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.
About this graph

Calibrated active content, concentration or activity compared with the stated same-unit specification. Each row uses its own labeled scale; no conversion from chromatographic purity is made.

Enlarge graph: Measured active content (opens in a new tab)

VIP is a vasoactive neuropeptide supplied by Apex Laboratory as a high-purity research peptide intended strictly for in-vitro laboratory research and development applications.

Compound Overview

Vasoactive Intestinal Peptide (VIP) is a 28-amino acid neuropeptide that activates VPAC1 and VPAC2 receptors (class B GPCRs). It plays roles in vasodilation, smooth muscle relaxation, neuromodulation, circadian rhythm regulation, and immune signaling. Research examines its broad-spectrum effects across multiple organ systems.

Research Background & Published Literature

Discovered in 1970 by Said and Mutt. Thousands of published studies in Journal of Neuroimmunology, Endocrinology, and Peptides. VIP is a key research tool in neuroendocrine, gastrointestinal, and immunological signaling studies.

Researchers interested in the published literature surrounding this compound can explore the following peer-reviewed resources for additional context on its mechanism of action, signaling pathways, and experimental applications in controlled laboratory settings:

Technical Specifications

  • Product Name: VIP
  • Classification: Vasoactive Neuropeptide
  • Structural Description: 28-amino acid neuropeptide hormone
  • CAS Number: 37221-79-7
  • Molecular Weight: 3326.82 g/mol
  • Purity: ≥99% (verified by HPLC and Mass Spectrometry)
  • Physical Form: Lyophilized (freeze-dried) powder
  • Intended Use: In-vitro research use only — not for human consumption

Storage, Handling & Stability Guidelines

Store lyophilized material at -20°C for long-term stability. After reconstitution with sterile diluent, refrigerate at 2–8°C and minimize freeze-thaw cycles by aliquoting working volumes according to your standard operating procedures.

  • Minimize time at ambient temperature during handling to preserve compound integrity.
  • Avoid moisture exposure by resealing vials promptly after each withdrawal.
  • Use appropriate personal protective equipment and follow your institution’s chemical safety protocols at all times.
  • Label all aliquots with the compound name, concentration, date of reconstitution, and operator initials for complete traceability.

Quality Assurance & Analytical Verification

Apex Laboratory applies a dual-verification quality protocol to every batch before it enters inventory. Each lot undergoes High-Performance Liquid Chromatography (HPLC) to confirm chromatographic purity and Mass Spectrometry (MS) to verify molecular identity and molecular weight. This two-step analytical process ensures that the material you receive meets our ≥99% purity standard with confirmed molecular integrity. Certificates of Analysis documenting these results are available in the batch verification panel on this page and in the COA library for your internal quality records.

Frequently Asked Questions

What is the primary research application of this compound?

This compound is classified as a vasoactive neuropeptide and is used in laboratory settings to study related signaling pathways and biological mechanisms in controlled in-vitro experiments.

What storage conditions are recommended?

For long-term storage, keep the lyophilized material at -20°C in a sealed container away from moisture and light. After reconstitution, refrigerate at 2–8°C and use within the recommended timeframe for your workflow.

Is this product approved for human use?

No. All compounds sold by Apex Laboratory are classified as chemical research reagents intended strictly for in-vitro laboratory research. They are not approved for human consumption, veterinary use, or any therapeutic application. Purchasers who imply intended bodily use will have their orders cancelled and accounts permanently suspended.

What documentation is available for this compound?

Certificates of Analysis (COA) with HPLC chromatograms and Mass Spectrometry data are available for current batches. View current COAs in our Lab Verified archive or request specific batch documentation through our contact page.

Is bulk ordering available?

Yes. For bulk quantities, custom packaging requirements, or recurring supply agreements, contact our team with the compound name, desired quantity, preferred dosage format, and your target delivery timeline. Volume pricing is available for qualifying orders.

Related Research Compounds

Researchers studying vasoactive neuropeptide pathways may also be interested in related compounds available from Apex Laboratory, including Oxytocin Acetate, DSIP, Gonadorelin Acetate. Explore our complete research catalog to browse all available peptides, reagents, and laboratory supplies, or visit our About page to learn more about our quality verification process.

Shipping, Packaging & Delivery

All orders placed before 2:00 PM Eastern Standard Time ship the same business day via tracked domestic carriers. Products are packaged in insulated, temperature-appropriate containers designed to preserve compound stability during transit. Upon delivery, transfer all materials to appropriate storage conditions immediately. For time-sensitive research protocols or special delivery requirements, contact our support team in advance to coordinate optimal shipping timing for your laboratory workflow.

Research Use Disclaimer

For in-vitro research use only. Not for human consumption. All products sold by Apex Laboratory are intended exclusively for qualified researchers, accredited laboratories, and educational institutions. Purchasers assume full responsibility for ensuring safe handling, proper storage, and compliance with all applicable federal, state, and local laws, regulations, and institutional policies governing the purchase and use of chemical research reagents.

Vial size

5mg, 10mg

Latest published COA configuration VIP - 10 mg
Latest published COA lot APX-2026-0510-V
COA issue date 2026-05-10
Issuing laboratory Apex Laboratory
COA approved by K. Norwood